Pharmaceutical Technology has featured Charlie Gibbons, Director of Compliance at Lachman Consultants in an article, AI and Digital Oversight in Pharma Supply Chains: PDA Regulatory Conference Insights, following his recent presentation at the PDA Global Regulatory Conference.
In his session at the conference, Charlie provided valuable insights into today’s evolving regulatory landscape, highlighting the practical challenges that companies face with Artificial Intelligence and offering strategies that can help bridge scientific innovation with compliance. His remarks underscored Lachman’s longstanding commitment to supporting clients as they navigate complex regulatory expectations with confidence.
The PharmTech article captures the impact of Charlie’s perspective and reinforces the importance of informed regulatory guidance in shaping industry dialogue. We encourage our readers to peruse the full article to learn more about the themes that Charlie addressed.
👉 Read the article in Pharmaceutical Technology: AI and Digital Oversight in Pharma Supply Chains: PDA Regulatory Conference Insights.
At Lachman, we are dedicated to thought leadership and collaboration that advances the industry. Thank you to Pharmaceutical Technology for the article and recognition of Charlie’s contributions.
